The value for the clinical application of urokinase combined with sodium tanshinon IIA in the treatment of cerebral thrombosis
10.3760/cma.j.issn.1008-6706.2012.07.012
- VernacularTitle:尿激酶联合丹参酮ⅡA治疗脑血栓形成80例分析
- Author:
Xianliang MENG
;
Linghua KONG
;
Aiping ZHU
- Publication Type:Journal Article
- Keywords:
Intracranial thrombosis;
Urinary plasminogen activator;
Tanshinone
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(7):985-986
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the value for the clinical application of urokinase combined with Sodium Tanshion ⅡA in the treatment of cerebral thrombosis.Methods160 cases with cerebral thrombosis in our hospital were chosen.They were randomly divided into A group with 80 cases and B group with 80 cases.A group was the observation group (Tanshion ⅡA Urokinase combined treatment group),B group was the control group (urine kinase treatment group).2 weeks treatment was a course.The efficacy of treatment in the two groups at the end was taken for statistical analysis.ResultsThe neurological deficits were significantly improved in A and B group before and after treatment (P ＜ 0.05,there was statistically significant).The neurological deficit scores in A group after treatment was significantly lower than group B ( P ＜ 0.05,there was statistically significant).The total effective rate was 95 ％ by the treatment of urokinase and Tanshion Ⅱa in A group which was higher than group B ( P ＜ 0.05,there was statistically significant difference).ConclusionThe treatment of urokinase combined with Sodium Tanshion Ⅱa could improve neurological deficits and improve the clinical therapeutic effect.
